extract: 2026-03-18-bluefors-interlune-he3-quantum-demand #1283
22 changed files with 318 additions and 14 deletions
|
|
@ -34,22 +34,28 @@ Dropout reached 1M+ subscribers by October 2025. Nebula revenue more than double
|
|||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2026-03-01-multiple-creator-economy-owned-revenue-statistics]] | Added: 2026-03-16*
|
||||
*Source: 2026-03-01-multiple-creator-economy-owned-revenue-statistics | Added: 2026-03-16*
|
||||
|
||||
88% of high-earning creators now leverage their own websites and 75% have membership communities, showing that owned infrastructure has become standard practice for successful creators, not an experimental edge case.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2026-03-01-cvleconomics-creator-owned-platforms-future-media-work]] | Added: 2026-03-16*
|
||||
*Source: 2026-03-01-cvleconomics-creator-owned-platforms-future-media-work | Added: 2026-03-16*
|
||||
|
||||
Dropout specifically generates $80-90M annual revenue with 1M+ subscribers, representing 18-21% of the total $430M creator-owned streaming market. This single-platform data point confirms the category-level aggregates and provides unit economics: $80-90 ARPU, 40-45% EBITDA margins, $3.0-3.3M revenue per employee.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-10-01-variety-dropout-superfan-tier-1m-subscribers]] | Added: 2026-03-16*
|
||||
*Source: 2025-10-01-variety-dropout-superfan-tier-1m-subscribers | Added: 2026-03-16*
|
||||
|
||||
Dropout crossed 1M paid subscribers in October 2025 with 31% YoY growth, representing ARR 'north of $30M' at 40-45% EBITDA margins. This adds a major data point: single creator-owned platform now at $30M+ ARR with 40 employees (~$750K revenue per employee), confirming the commercial viability at scale.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-00-00-markrmason-dropout-streaming-model-community-economics]] | Added: 2026-03-18*
|
||||
|
||||
Dropout contributes $30M+ ARR to the indie streaming category as of 2023, with 1M+ subscribers by October 2025. Platform is profitable and distributed profit sharing to all contributors earning $1+ in 2023. This adds another data point to the commercial scale thesis for creator-owned streaming.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -35,6 +35,12 @@ Claynosaurz-Mediawan partnership provides concrete implementation of the co-crea
|
|||
|
||||
Dropout, Nebula, and Critical Role all serve niche audiences with high willingness-to-pay through community-driven (not algorithm-driven) discovery. Critical Role's Beacon explicitly segments content by engagement level: some YouTube/Twitch-first (broad reach), some Beacon-exclusive (high engagement), some early access on Beacon (intermediate engagement). This tiered access structure maps directly to the fanchise stack concept, with free content as entry point and owned-platform subscriptions as higher engagement tier. Nebula's ~2/3 annual membership rate indicates subscribers making deliberate, high-commitment choices rather than casual consumption.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2026-03-02-transformativeworks-ao3-statistics-2025-update]] | Added: 2026-03-18*
|
||||
|
||||
AO3 represents the 'co-creation without ownership' configuration on the fanchise stack: 17M+ fan-created works across 77,100+ fandoms, 10M registered users, all content freely accessible with no financial stake. The platform's 22% YoY growth and 5M comments/month demonstrate sustained engagement at the co-creation rung without requiring ownership mechanisms. This establishes co-creation as independently viable, not merely a stepping stone to ownership.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -32,10 +32,16 @@ The timing matters: this is the first major entertainment trade publication to a
|
|||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-10-01-variety-dropout-superfan-tier-1m-subscribers]] | Added: 2026-03-16*
|
||||
*Source: 2025-10-01-variety-dropout-superfan-tier-1m-subscribers | Added: 2026-03-16*
|
||||
|
||||
Critical Role's Beacon launched May 2024 at $5.99/month and experienced ~20% Twitch subscriber migration post-launch, showing owned platform adoption even for established creators with large platform audiences. Beacon and Dropout now collaborating on talent (Brennan Lee Mulligan) rather than competing.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-00-00-markrmason-dropout-streaming-model-community-economics]] | Added: 2026-03-18*
|
||||
|
||||
Dropout reached $30M+ ARR and profitability in 2023 as a niche TTRPG/game show platform. Dimension 20 sold out Madison Square Garden in January 2025. This adds TTRPG actual play to the indie streaming category alongside other verticals, with similar patterns: niche focus, subscription-first, organic social distribution.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -302,6 +302,12 @@ Beast Industries' $5B valuation and revenue trajectory ($899M → $1.6B → $4.7
|
|||
|
||||
Dropout's behavior confirms the loss-leader prediction: they maintain identical pricing for 3+ years, grandfather legacy subscribers, and explicitly encourage password sharing — all behaviors that treat content as customer acquisition rather than direct monetization. The 40-45% margins come from eliminating distributor costs, not from maximizing per-user extraction.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2026-03-02-transformativeworks-ao3-statistics-2025-update]] | Added: 2026-03-18*
|
||||
|
||||
AO3 reached 17M+ works and 879M weekly page views (125M daily) with zero editorial curation, using only folksonomy tagging and community self-selection (kudos, bookmarks, comments as social signals). The platform grew 22% year-over-year in 2025 despite being 17 years old, demonstrating that community filtering scales without quality gatekeeping. AO3's 'Don't Like, Don't Read' policy with tag-based discoverability proves community-filtered content can achieve massive scale.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -41,6 +41,12 @@ England's social prescribing provides international counterpoint: 1.3M annual re
|
|||
|
||||
Community health worker programs demonstrate the same payment boundary stall: only 20 states have Medicaid State Plan Amendments for CHW reimbursement 17 years after Minnesota's 2008 approval, despite 39 RCTs showing $2.47 ROI. The billing infrastructure bottleneck is identical to Z-code documentation failure — SPAs typically use 9896x CPT codes but uptake remains slow because community-based organizations lack contracting infrastructure and Medicaid does not cover provider travel costs (the largest CHW overhead expense). 7 states have established dedicated CHW offices and 6 enacted new reimbursement legislation in 2024-2025, but the gap between evidence (strong) and operational infrastructure (absent) mirrors the SDOH screening-to-action gap.
|
||||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2025-01-01-produce-prescriptions-diabetes-care-critique]] | Added: 2026-03-18*
|
||||
|
||||
The Diabetes Care perspective challenges the 'strong ROI' claim for SDOH interventions by questioning whether produce prescriptions—a specific SDOH intervention—actually produce clinical outcomes. The observational evidence showing improvements may reflect methodological artifacts (self-selection, regression to mean) rather than true causal effects. This suggests the ROI evidence for SDOH interventions may be weaker than claimed, particularly for single-factor interventions like food provision.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -41,16 +41,22 @@ The claim that budget scoring "systematically" undervalues prevention requires e
|
|||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-11-01-aspe-medicare-anti-obesity-medication-coverage]] | Added: 2026-03-16*
|
||||
*Source: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage | Added: 2026-03-16*
|
||||
|
||||
The CBO vs. ASPE divergence on Medicare GLP-1 coverage provides concrete evidence: CBO projects $35B in additional spending (2026-2034) using budget scoring methodology, while ASPE projects net savings of $715M over 10 years using clinical economics methodology that includes downstream event avoidance. The $35.7B gap between these estimates demonstrates how budget scoring rules structurally disadvantage preventive interventions. CBO uses conservative uptake assumptions and doesn't fully count avoided hospitalizations and disease progression within the 10-year window, while ASPE includes 38,950 CV events avoided and 6,180 deaths avoided. Both are technically correct but answer different questions—budget impact vs. clinical economics.
|
||||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2025-01-01-gimm-hoffman-chw-rct-scoping-review]] | Added: 2026-03-18*
|
||||
*Source: 2025-01-01-gimm-hoffman-chw-rct-scoping-review | Added: 2026-03-18*
|
||||
|
||||
IMPaCT's $2.47 Medicaid ROI within the same fiscal year demonstrates that at least one category of preventive intervention (CHW programs) generates returns fast enough to be captured within annual budget cycles, not just 10-year windows. This suggests the scoring methodology problem may be less severe for interventions with rapid return profiles.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-10-31-cms-vbid-model-termination-food-medicine]] | Added: 2026-03-18*
|
||||
|
||||
VBID termination was driven by $2.3B excess costs in CY2021-2022, measured within a short window that could not capture long-term savings from food-as-medicine interventions. CMS cited 'unprecedented' excess costs as justification, demonstrating how short-term cost accounting drives policy decisions even for preventive interventions with strong theoretical long-term ROI.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -53,6 +53,12 @@ WHO's three-pillar framework for GLP-1 obesity treatment explicitly positions me
|
|||
|
||||
While social determinants predict health outcomes in observational studies, RCT evidence from food-as-medicine interventions shows that directly addressing social determinants (food insecurity) does not automatically improve clinical outcomes. The AHA 2025 systematic review of 14 US RCTs found Food Is Medicine programs improve diet quality and food security but "impact on clinical outcomes was inconsistent and often failed to reach statistical significance." This suggests the causal pathway from social determinants to health is more complex than simple resource provision.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-01-01-produce-prescriptions-diabetes-care-critique]] | Added: 2026-03-18*
|
||||
|
||||
The Diabetes Care perspective provides a specific mechanism example: produce prescription programs may improve food security (a social determinant) without improving clinical outcomes (HbA1c, diabetes control) because the causal pathway from social disadvantage to disease is not reversible through single-factor interventions. This demonstrates the 10-20% medical care contribution in practice—addressing one SDOH factor (food access) doesn't overcome the compound effects of poverty, stress, and social disadvantage.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -30,6 +30,12 @@ DOE Isotope Program's purchase of lunar helium-3 from Interlune extends the gove
|
|||
|
||||
VIPER cancellation shows the transition is not strategic but reactive. Government didn't choose to buy commercial ISRU characterization services—it cancelled its own mission due to cost/schedule failure, and commercial operators filled the gap with different objectives (Interlune mapping helium-3 for commercial purposes, not comprehensive volatiles characterization). The commercial replacements are not service providers fulfilling government requirements; they're independent operators pursuing their own resource interests while government capability is absent.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2026-03-18-bluefors-interlune-he3-quantum-demand]] | Added: 2026-03-18*
|
||||
|
||||
U.S. DOE Isotope Program signed contract for 3 liters of lunar He-3 by April 2029, explicitly described as 'first government purchase of space-extracted resource.' Government is buying the product, not building the extraction system.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -24,6 +24,12 @@ Every other space business — manufacturing, mining, refueling, habitats — is
|
|||
|
||||
Astrobotic's LunaGrid is the first commercial attempt to solve the lunar power constraint with a power-as-a-service model. LunaGrid-Lite will demonstrate 1 kW transmission over 500m of cable in 2026-2027, with full commissioning of a 10 kW VSAT system at the lunar south pole in 2028. The $34.6M NASA contract and Honda partnership for regenerative fuel cells (to survive 14-day lunar nights) confirms that power infrastructure is the critical path for sustained lunar operations.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2026-03-18-astrobotic-lunagrid-lite-cdr-flight-model]] | Added: 2026-03-18*
|
||||
|
||||
LunaGrid-Lite completed CDR in August 2025 and is fabricating flight hardware for a mid-2026 lunar deployment. The system will demonstrate 1 kW power transmission over 500m of cable. However, the scaling roadmap reveals a critical gap: 1 kW demo (2026) → 10 kW VSAT (2028) → 50 kW VSAT-XL (later). Commercial-scale He-3 extraction requires ~1.2 MW based on Interlune's excavator specs (100 tonnes/hour at 10x less power than 12 MW heat-based systems). This creates a 5-7 year gap between LunaGrid's demonstration capability and extraction-scale power requirements, making power availability a binding constraint on the 2029 pilot plant timeline unless supplemented by nuclear fission surface power.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -24,6 +24,12 @@ This creates a strategic concentration risk: the most critical resource for the
|
|||
|
||||
Interlune's DOE contract for helium-3 delivery by 2029 and Bluefors contract for 1,000 liters annually (~$300M value) demonstrate that helium-3 may achieve commercial viability before water because it has immediate high-value terrestrial customers (quantum computing coolant) willing to pay extraction-justifying prices, while water faces competition from falling Earth launch costs for in-space applications.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2026-03-18-bluefors-interlune-he3-quantum-demand]] | Added: 2026-03-18*
|
||||
|
||||
He-3 for quantum computing represents a different resource category: first commercially contracted lunar surface extraction product with terrestrial buyers at premium prices ($200-300M/year contract value). Water is keystone for in-space operations; He-3 is first export product to Earth. Scope qualifier needed: water dominates in-space resource utilization, but He-3 may be the first economically viable lunar mining product.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,36 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "voluntary-premium-subscription-tiers-align-fan-incentives-with-creator-success-without-ownership-infrastructure.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "niche-subscription-platforms-achieve-profitability-through-creative-stability-not-scale-when-business-model-is-radically-boring.md",
|
||||
"issues": [
|
||||
"no_frontmatter"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 6,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"voluntary-premium-subscription-tiers-align-fan-incentives-with-creator-success-without-ownership-infrastructure.md:set_created:2026-03-18",
|
||||
"voluntary-premium-subscription-tiers-align-fan-incentives-with-creator-success-without-ownership-infrastructure.md:stripped_wiki_link:community-ownership-accelerates-growth-through-aligned-evang",
|
||||
"voluntary-premium-subscription-tiers-align-fan-incentives-with-creator-success-without-ownership-infrastructure.md:stripped_wiki_link:fanchise-management-is-a-stack-of-increasing-fan-engagement-",
|
||||
"niche-subscription-platforms-achieve-profitability-through-creative-stability-not-scale-when-business-model-is-radically-boring.md:set_created:2026-03-18",
|
||||
"niche-subscription-platforms-achieve-profitability-through-creative-stability-not-scale-when-business-model-is-radically-boring.md:stripped_wiki_link:indie-streaming-platforms-emerged-as-category-by-2024-with-c",
|
||||
"niche-subscription-platforms-achieve-profitability-through-creative-stability-not-scale-when-business-model-is-radically-boring.md:stripped_wiki_link:creator-owned-streaming-infrastructure-has-reached-commercia"
|
||||
],
|
||||
"rejections": [
|
||||
"voluntary-premium-subscription-tiers-align-fan-incentives-with-creator-success-without-ownership-infrastructure.md:missing_attribution_extractor",
|
||||
"niche-subscription-platforms-achieve-profitability-through-creative-stability-not-scale-when-business-model-is-radically-boring.md:no_frontmatter"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -0,0 +1,36 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 6,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:set_created:2026-03-18",
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:stripped_wiki_link:value-based-care-transitions-stall-at-the-payment-boundary-b",
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:stripped_wiki_link:SDOH-interventions-show-strong-ROI-but-adoption-stalls-becau",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:set_created:2026-03-18",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:stripped_wiki_link:value-based-care-transitions-stall-at-the-payment-boundary-b",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:stripped_wiki_link:federal-budget-scoring-methodology-systematically-undervalue"
|
||||
],
|
||||
"rejections": [
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:missing_attribution_extractor",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -0,0 +1,24 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "produce-prescriptions-may-improve-food-security-without-clinical-outcomes-because-food-insecurity-proxies-poverty.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 1,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"produce-prescriptions-may-improve-food-security-without-clinical-outcomes-because-food-insecurity-proxies-poverty.md:set_created:2026-03-18"
|
||||
],
|
||||
"rejections": [
|
||||
"produce-prescriptions-may-improve-food-security-without-clinical-outcomes-because-food-insecurity-proxies-poverty.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -0,0 +1,32 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "helium-3-is-the-first-commercially-contracted-lunar-resource-with-terrestrial-buyers-paying-premium-prices-before-extraction-infrastructure-exists.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "helium-3-demand-structure-avoids-the-launch-cost-paradox-because-it-has-no-earth-launchable-substitute-at-any-price.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 2,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"helium-3-is-the-first-commercially-contracted-lunar-resource-with-terrestrial-buyers-paying-premium-prices-before-extraction-infrastructure-exists.md:set_created:2026-03-18",
|
||||
"helium-3-demand-structure-avoids-the-launch-cost-paradox-because-it-has-no-earth-launchable-substitute-at-any-price.md:set_created:2026-03-18"
|
||||
],
|
||||
"rejections": [
|
||||
"helium-3-is-the-first-commercially-contracted-lunar-resource-with-terrestrial-buyers-paying-premium-prices-before-extraction-infrastructure-exists.md:missing_attribution_extractor",
|
||||
"helium-3-demand-structure-avoids-the-launch-cost-paradox-because-it-has-no-earth-launchable-substitute-at-any-price.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -7,9 +7,13 @@ date: 2024-00-00
|
|||
domain: entertainment
|
||||
secondary_domains: []
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: medium
|
||||
tags: [dropout, streaming, community-economics, subscription, superfan, dimension-20, TTRPG, actual-play, indie-streaming]
|
||||
processed_by: clay
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["indie-streaming-platforms-emerged-as-category-by-2024-with-convergent-structural-patterns-across-content-verticals.md", "creator-owned-streaming-infrastructure-has-reached-commercial-scale-with-430M-annual-creator-revenue-across-13M-subscribers.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -64,3 +68,15 @@ Substack analysis of Dropout's streaming business model. Published approximately
|
|||
PRIMARY CONNECTION: [[community ownership accelerates growth through aligned evangelism not passive holding]]
|
||||
WHY ARCHIVED: Dropout is the strongest counter-evidence to the assumption that community economics requires Web3 — subscription models can produce equivalent alignment. Key data point for scoping the "ownership" claim.
|
||||
EXTRACTION HINT: Extract the superfan tier / voluntary over-payment as the core novel observation; use the financial data ($30M+ ARR, profitable, profit-sharing) to substantiate claims about community economics without blockchain
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Dropout ARR: $30M+ (2023)
|
||||
- Dropout subscribers: 1M+ (October 2025)
|
||||
- Dropout subscriber growth: 100% in 2023
|
||||
- Dropout superfan tier price: $129.99/year (launched 2025)
|
||||
- Dropout standard subscription: ~$60-70/year
|
||||
- Dropout first paid marketing: late 2022
|
||||
- Dimension 20 sold out Madison Square Garden (January 2025)
|
||||
- Brennan Lee Mulligan signed 3-year Dropout deal while joining Critical Role Campaign 4
|
||||
- Dropout distributed profit sharing to anyone earning $1+ in 2023
|
||||
|
|
|
|||
|
|
@ -7,10 +7,14 @@ date: 2024-10-31
|
|||
domain: health
|
||||
secondary_domains: [internet-finance]
|
||||
format: announcement
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [vbid, cms, medicare-advantage, food-as-medicine, payment-policy, supplemental-benefits, ssbci]
|
||||
flagged_for_rio: ["CMS VBID termination is a major payment model policy shift — intersects with Rio's VBC and MA economics analysis"]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -68,3 +72,13 @@ CMS announced termination of the Medicare Advantage Value-Based Insurance Design
|
|||
PRIMARY CONNECTION: The structural misalignment claim in VBC (payment boundary stalls) — this is a new instance where the payment infrastructure for non-clinical intervention is contracting
|
||||
WHY ARCHIVED: Policy event that changes the funding landscape for food-as-medicine — essential context for any claim about FIM scalability or the attractor state toward prevention
|
||||
EXTRACTION HINT: Extract the payment mechanism claim (VBID ends, SSBCI excludes low-income) as a concrete policy-state change. Also flag the MAHA rhetoric vs. funding reality as a cross-domain political economy observation.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- VBID excess costs: $2.3 billion in CY2021, $2.2 billion in CY2022
|
||||
- ~2,000 MA plans participated in VBID at peak
|
||||
- Food/nutrition assistance was the most common VBID supplemental benefit in 2024
|
||||
- 6 of 8 states with active 1115 waivers for food-as-medicine programs were placed under CMS review
|
||||
- VBID termination announced by Biden administration October/November 2024
|
||||
- VBID ends December 31, 2025
|
||||
- SSBCI (replacement pathway) does not allow eligibility based on low income or socioeconomic disadvantage
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-01-01
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: perspective
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: medium
|
||||
tags: [produce-prescriptions, food-is-medicine, diabetes, evidence-critique, causal-inference, intervention-design]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md", "SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -62,3 +66,10 @@ Perspective piece in Diabetes Care (American Diabetes Association) with the poin
|
|||
PRIMARY CONNECTION: The food-as-medicine causal inference gap claim from Session 1
|
||||
WHY ARCHIVED: ADA's own journal questioning produce prescription evidence — the clinical community's internal skepticism, not external debunking
|
||||
EXTRACTION HINT: The distinction between "food matters for health" (proven) and "produce vouchers improve diabetes outcomes" (unproven) is the precise claim to extract
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Diabetes Care published a perspective titled 'Food Is Medicine, but Are Produce Prescriptions?' in 2023
|
||||
- Observational evaluations of produce prescriptions include multisite 9-program studies and Recipe4Health
|
||||
- Produce prescription programs showing HbA1c improvements typically enroll patients with baseline HbA1c >9%
|
||||
- The American Diabetes Association's journal is questioning the evidence standard for produce prescriptions
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2026-03-02
|
|||
domain: entertainment
|
||||
secondary_domains: []
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: medium
|
||||
tags: [ao3, fanfiction, community-governance, collaborative-fiction, scale, statistics]
|
||||
processed_by: clay
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership.md", "fanchise management is a stack of increasing fan engagement from content extensions through co-creation and co-ownership.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -52,3 +56,16 @@ Governance model: "Fan-run, donor-supported organization staffed by volunteers."
|
|||
PRIMARY CONNECTION: [[the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership]]
|
||||
WHY ARCHIVED: AO3 is the existence proof for community-governed creative production at massive scale without editorial authority — directly tests the "distributed authorship = coherent narrative?" question from Session 6
|
||||
EXTRACTION HINT: Focus on the no-curation model + scale as evidence for the governance spectrum claim (AO3 end = parallel narratives); contrast with SCP's light-curation model
|
||||
|
||||
|
||||
## Key Facts
|
||||
- AO3 had 17,020,000+ fanworks as of March 2, 2026
|
||||
- AO3 spans 77,100+ fandoms
|
||||
- AO3 reached 10 million registered users in January 2026
|
||||
- AO3 recorded 879 million page views in the first week of 2026 (~125 million daily)
|
||||
- AO3 recorded 5 million comments in December 2025, a first-time milestone
|
||||
- November 2025 generated 146.6 million MORE weekly page views than November 2024 (22% growth)
|
||||
- AO3 traffic peaks on Sundays (UTC) and dips Thursday-Friday
|
||||
- AO3 experienced a July 2025 database outage requiring bookmark migration
|
||||
- AO3 has approximately 700+ volunteers serving as tag wranglers, support staff, and coders
|
||||
- AO3 was founded in 2008 by the Organization for Transformative Works
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2026-03-11
|
|||
domain: ai-alignment
|
||||
secondary_domains: []
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: medium
|
||||
tags: [investment, oversight, governance-deficit, deployment-pressure, AI-scale, accountability]
|
||||
processed_by: theseus
|
||||
processed_date: 2026-03-18
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 0 claims, 0 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -62,3 +66,11 @@ PRIMARY CONNECTION: [[technology advances exponentially but coordination mechani
|
|||
WHY ARCHIVED: Provides quantitative scale data ($405B/$650B investment, $600B Sequoia gap, 63% governance deficit) that gives concrete numbers to the abstract coordination gap. Most useful as evidence enrichment for existing claims rather than new claim extraction.
|
||||
|
||||
EXTRACTION HINT: Use primarily as evidence enrichment for existing claims about investment-governance mismatch. Note the $600B Sequoia gap as the specific monetization pressure mechanism.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Major tech firms projected to spend ~$405 billion building AI infrastructure in 2025
|
||||
- Four largest tech providers may invest $650 billion more in 2026
|
||||
- Sequoia Capital identified a $600 billion gap between AI infrastructure spending and AI earnings
|
||||
- 63% of surveyed organizations lack AI governance policies (IBM research)
|
||||
- Regulatory timelines measured in years while AI release cycles measured in weeks to hours
|
||||
|
|
|
|||
|
|
@ -7,9 +7,12 @@ date: 2025-10-28
|
|||
domain: space-development
|
||||
secondary_domains: []
|
||||
format: news
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [clps, griffin, astrobotic, interlune, lunar-landing, he3-mapping, viper-replacement, landing-reliability]
|
||||
processed_by: astra
|
||||
processed_date: 2026-03-18
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -58,3 +61,15 @@ Astrobotic delayed its Griffin Mission One (GM1/Griffin-1) lunar lander to no ea
|
|||
PRIMARY CONNECTION: CLPS landing reliability claim (from prior research session — 1 of 5 clean success rate)
|
||||
WHY ARCHIVED: Critical milestone for He-3 extraction commercial case and LunaGrid power demo; the correlated risk (both on same lander) is the key insight for KB
|
||||
EXTRACTION HINT: The double-payload concentration risk (He-3 camera + LunaGrid-Lite both on Griffin-1) is a novel observation that creates a claim about infrastructure dependency concentration in early lunar commercial activity.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Astrobotic Griffin-1 delayed from 2025 to NET July 2026
|
||||
- Griffin-1 CLPS task order value: $322M
|
||||
- Griffin-1 carries FLIP rover (Venturi Astrolab), Interlune multispectral camera, LunaGrid-Lite, and NASA/ESA/commercial payloads
|
||||
- Griffin-1 target: lunar south pole near permanently shadowed regions
|
||||
- Griffin-1 launch vehicle: SpaceX Falcon Heavy
|
||||
- Griffin-1 replaces cancelled VIPER mission (cancelled July 2024)
|
||||
- Current He-3 concentration estimates: 1.4-15 ppb in sunlit regolith, possibly 50 ppb in permanently shadowed regions (from orbital remote sensing only)
|
||||
- Astrobotic Peregrine mission failed January 2024 due to propellant leak
|
||||
- Griffin lander is first-generation hardware with no flight heritage
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-08-20
|
|||
domain: space-development
|
||||
secondary_domains: []
|
||||
format: press-release
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [lunar-power, lunagrid, astrobotic, infrastructure, isru-enabler, power-constraint]
|
||||
processed_by: astra
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["power is the binding constraint on all space operations because every capability from ISRU to manufacturing to life support is power-limited.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -58,3 +62,15 @@ Astrobotic announced in August 2025 that LunaGrid-Lite completed Critical Design
|
|||
PRIMARY CONNECTION: [[power is the binding constraint on all space operations because every capability from ISRU to manufacturing to life support is power-limited]]
|
||||
WHY ARCHIVED: Direct evidence of commercial lunar power infrastructure progress; critical prerequisite for He-3 extraction and other surface ISRU; the 1kW→50kW scaling timeline is a key constraint on commercial lunar operations
|
||||
EXTRACTION HINT: The key insight is the scaling gap — 1kW demo (2026) vs. extraction-scale requirements (~1 MW+). This creates a timeline tension: Interlune's 2029 pilot plant would need more power than LunaGrid can deliver by then unless nuclear power (fission surface power) supplements the solar system.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- LunaGrid-Lite CDR completed August 2025
|
||||
- LunaGrid-Lite will transmit 1 kW over 500m of cable
|
||||
- LunaGrid-Lite deployment target: mid-2026
|
||||
- NASA contract value for LunaGrid-Lite: $34.6M
|
||||
- LunaGrid VSAT planned for 2028 with 10 kW capacity at lunar south pole
|
||||
- LunaGrid VSAT-XL planned for 50 kW capacity (timeline unspecified)
|
||||
- Honda partnership for regenerative fuel cells to survive 14-day lunar night
|
||||
- System Integration Review (SIR) planned for Q4 2025
|
||||
- Flight-ready target: Q2 2026
|
||||
|
|
|
|||
|
|
@ -7,11 +7,15 @@ date: 2025-09-17
|
|||
domain: space-development
|
||||
secondary_domains: [ai-alignment]
|
||||
format: press-release
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [helium-3, quantum-computing, demand-signal, interlune, bluefors, lunar-resources, commercial-contracts]
|
||||
flagged_for_rio: ["First private-sector anchor buyer for a space-extracted resource — capital formation implications and contract structure analysis needed"]
|
||||
flagged_for_theseus: ["Quantum computing infrastructure bottleneck: He-3 supply constrains quantum computer scaling — alignment implications if quantum AI depends on lunar supply"]
|
||||
processed_by: astra
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["governments are transitioning from space system builders to space service buyers which structurally advantages nimble commercial providers.md", "water is the strategic keystone resource of the cislunar economy because it simultaneously serves as propellant life support radiation shielding and thermal management.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -57,3 +61,14 @@ Bluefors (Finland, world's leading cryogenic cooling systems manufacturer) and I
|
|||
PRIMARY CONNECTION: [[falling launch costs paradoxically both enable and threaten in-space resource utilization by making infrastructure affordable while competing with the end product]] — He-3 explicitly avoids this paradox since it has no Earth-launchable substitute
|
||||
WHY ARCHIVED: Core evidence for "He-3 as first viable commercial lunar resource" thesis; demand structure analysis is the key insight
|
||||
EXTRACTION HINT: The dual-claim opportunity here is (1) the empirical fact of contracted demand, and (2) the structural analysis of why He-3 avoids the ISRU paradox. Extract these as separate claims with appropriate confidence levels.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Bluefors contract: up to 10,000 liters/year lunar He-3, 2028-2037 delivery
|
||||
- Implied contract value: $200-300M/year at $20,000-$30,000/liter
|
||||
- DOE Isotope Program: 3 liters by April 2029
|
||||
- Over 700 dilution refrigerator systems installed globally by 2023
|
||||
- Global terrestrial He-3 supply: low tens of kilograms/year from tritium decay
|
||||
- Terrestrial He-3 prices: $2,000-$20,000+ per liter, surged 400%+ recently
|
||||
- Dilution refrigerators operate below 0.3 Kelvin
|
||||
- Every major superconducting quantum computer (IBM, Google, D-Wave) uses He-3-dependent cooling
|
||||
|
|
|
|||
Loading…
Reference in a new issue